Congenital neural diseases are a group of disorders caused by developmental aberrations in the central nervous system of an unborn baby, almost always occurring before birth. These rare conditions often cause permanent, irreversible neurological impairment, often manifesting as severe physical and mental disability. The most common cause of congenital neural diseases is chromosomal anomalies. About half of affected infants have a chromosomal abnormality such as trisomy, or an extra copy of a chromosome. Many genetic disorders can also cause congenital neural diseases, including tuberous sclerosis, neurofibromatosis, and fragile X syndrome. Additionally, environmental factors such as infection or antenatal maternal drug use can also lead to congenital neural diseases. Clinical presentation of congenital neural diseases can vary widely, often manifesting as motor impairments, cognitive disabilities, developmental delays, and sometimes, seizures. Cognitive impairments can range from mild deficits in language processing to severe limitations in intellectual functioning. In some instances, congenital neural diseases may lead to a complete absence of motor function and muscle atrophy. Diagnosing congenital neural diseases often requires genetic testing, a review of the mother’s antenatal history, a physical exam, and imaging scans of the brain. Treatment is usually focused on managing the symptoms of the condition and providing supportive therapies. Treatment options may include medications, physical therapy, occupational therapy, and even surgical procedures. Since congenital neural diseases are rarely curable, early diagnosis and supportive care are key to managing symptoms and improving the quality of life for individuals living with such conditions. Caregivers should be familiar with the resources available for families affected by these disorders, to ensure the best quality of life for their loved ones.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom